Suppr超能文献

改善银屑病患者群体的心血管结局。银屑病与心血管疾病——患者的认知、观点及实践。

Improving Cardiovascular Outcomes in the Psoriasis Cohort. Psoriasis and Cardiovascular Disease-Patient Knowledge, Perspectives and Practice.

作者信息

Smith Annika, Lai Belinda, Chow Clara K, Zaman Sarah

机构信息

Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia.

出版信息

Australas J Dermatol. 2025 Sep;66(6):338-343. doi: 10.1111/ajd.14528. Epub 2025 Jun 2.

Abstract

BACKGROUND AND STUDY AIMS

Patient perspectives on psoriasis as a systemic disease, with its heightened risk of cardiovascular disease (CVD), are unclear. Approaches to cardiovascular risk factor screening and management vary in this cohort. This study aimed to ascertain knowledge, practice and perceptions of patients with respect to psoriasis and CVD, CV risk factor screening and management.

METHODS

This cross-sectional study consisted of a self-administered questionnaire capturing demographic characteristics, knowledge of the association between psoriasis and CVD, and perspectives on cardiovascular risk factor screening and management. This was distributed to psoriasis patients in public and private clinic settings. The survey data was assessed with the use of descriptive statistics.

RESULTS

A total of 102 patients with psoriasis were surveyed. The majority of respondents were male 52%, (53/102), 46-60 years old 30.4% (31/102), with longstanding psoriasis (> 20 years), 42.2.% (43/102). Most patients nominated a dermatologist in a public hospital setting as the primary clinician responsible for their psoriasis management 71.6% (73/102). A total of 20.6% (21/102) psoriasis patients surveyed indicated knowledge of the association between CVD and psoriasis, and 22.5% (23/102) agreed that psoriasis was associated with worse CVD outcomes compared to the general population. 63.7% (65/102) indicated they had undergone CV risk factor screening in the last year, with most nominating general practitioners (GPs) 38.4% (38/99), followed by cardiologists 14.1% (14/99), then dermatologists 9.1% (9/99), as the clinician who performed this CV RF screening. A total of 68.6% (70/102) responded they did not currently have a treating cardiologist, while 34.3% (35/102) nominated a Cardiologist as their preferred clinician to facilitate CVD risk factor screening/management, 23.5% (24/102) indicated a preference for a multidisciplinary team, 17.6% (18/102) nominated GPs and 6.9% (7/102) nominated the dermatologist.

CONCLUSION

There is a need for improved patient education regarding the relationship between psoriasis and CVD. Heightened awareness around cardiovascular risk may serve as an impetus for patients to seek relevant cardiovascular risk factor screening, management and pursue healthy lifestyle behaviours.

摘要

背景与研究目的

患者对于银屑病作为一种全身性疾病及其心血管疾病(CVD)风险增加的看法尚不清楚。该队列中对心血管危险因素的筛查和管理方法各不相同。本研究旨在确定患者对银屑病与CVD、心血管危险因素筛查和管理的了解、实践和看法。

方法

这项横断面研究采用自填式问卷,收集人口统计学特征、对银屑病与CVD关联的了解,以及对心血管危险因素筛查和管理的看法。问卷分发给公立和私立诊所的银屑病患者。使用描述性统计分析调查数据。

结果

共对102例银屑病患者进行了调查。大多数受访者为男性,占52%(53/102),年龄在46 - 60岁之间,占30.4%(31/102),患有长期银屑病(>20年),占42.2%(43/102)。大多数患者指定公立医院的皮肤科医生为负责其银屑病治疗的主要临床医生,占71.6%(73/102)。在接受调查的银屑病患者中,共有20.6%(21/102)表示了解CVD与银屑病之间的关联,22.5%(23/102)同意与普通人群相比,银屑病与更差的CVD结局相关。63.7%(65/102)表示他们在过去一年接受了心血管危险因素筛查,大多数指定全科医生(GP),占38.4%(38/99),其次是心脏病专家,占14.1%(14/99),然后是皮肤科医生,占9.1%(9/99),作为进行此项心血管危险因素筛查的临床医生。共有68.6%(70/102)的受访者表示他们目前没有主治心脏病专家,而34.3%(35/102)指定心脏病专家为他们首选的临床医生以促进心血管危险因素筛查/管理,23.5%(24/102)表示倾向于多学科团队,17.6%(18/102)指定全科医生,6.9%(7/102)指定皮肤科医生。

结论

需要加强关于银屑病与CVD之间关系的患者教育。提高对心血管风险的认识可能促使患者寻求相关的心血管危险因素筛查、管理并采取健康的生活方式。

相似文献

4
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.

本文引用的文献

1
Specialist and Patient Perspectives on Strategies to Improve Cardiovascular Disease Prevention Among Persons Living with Psoriatic Disease.
J Psoriasis Psoriatic Arthritis. 2022 Oct;7(4):174-186. doi: 10.1177/24755303221101848. Epub 2022 Jun 3.
2
Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies - Adult patients.
Australas J Dermatol. 2023 Nov;64(4):476-487. doi: 10.1111/ajd.14138. Epub 2023 Jul 28.
4
Psoriasis and Cardiovascular Diseases: An Immune-Mediated Cross Talk?
Front Immunol. 2022 May 24;13:868277. doi: 10.3389/fimmu.2022.868277. eCollection 2022.
5
Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.
Front Cardiovasc Med. 2022 Mar 25;9:829709. doi: 10.3389/fcvm.2022.829709. eCollection 2022.
6
Current Concepts of Psoriasis Immunopathogenesis.
Int J Mol Sci. 2021 Oct 26;22(21):11574. doi: 10.3390/ijms222111574.
7
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis.
Ann Rheum Dis. 2022 Jan;81(1):68-73. doi: 10.1136/annrheumdis-2021-219961. Epub 2021 Jun 18.
8
Psoriasis and Cardiovascular Risk: A Comprehensive Review.
Adv Ther. 2020 May;37(5):2017-2033. doi: 10.1007/s12325-020-01346-6. Epub 2020 Apr 20.
9
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities.
J Am Acad Dermatol. 2019 Apr;80(4):1073-1113. doi: 10.1016/j.jaad.2018.11.058. Epub 2019 Feb 13.
10
Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
Front Immunol. 2018 Jun 1;9:1234. doi: 10.3389/fimmu.2018.01234. eCollection 2018.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验